Cleared Traditional

K896144 - AUTOSCAN, AUTOSTRIP AND AUTOCONTROL

K896144 is an FDA 510(k) clearance for AUTOSCAN, manufactured by Cascade Medical, Inc.. The device is a Class 2 Chemistry device with product code CGA cleared through the Traditional 510(k) pathway after a 57-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1989
Decision
57d
Days
Class 2
Risk

K896144 is an FDA 510(k) clearance for the AUTOSCAN, AUTOSTRIP AND AUTOCONTROL. Classified as Glucose Oxidase, Glucose (product code CGA), Class II - Special Controls.

Submitted by Cascade Medical, Inc. (Eden Prairie, US). The FDA issued a Cleared decision on December 19, 1989 after a review of 57 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K896144

510(k) Number K896144 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 23, 1989
Decision Date December 19, 1989
Days to Decision 57 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 89d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CGA Device Classification - Class 2, Special Controls

Product Code CGA Glucose Oxidase, Glucose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGA Glucose Oxidase, Glucose

All 400
Devices cleared under the same product code (CGA) and FDA review panel - the closest regulatory comparables to K896144.
MEDISENSE PEN 2/COMPANION 2 BLOOD GLUCOSE SYSTEM
K901613 · Medisense, Inc. · Jul 1990
GLUCOMETER GX BLOOD GLUCOSE METER
K897015 · Heraeus Kulzer, Inc. · Mar 1990
SATELLITE G BLOOD GLUCOSE MONITORING SYSTEM
K896951 · Medisense, Inc. · Feb 1990
QUANTAI UG REAGENT STRIP
K893661 · Quantai Biotronics, Inc. · Nov 1989
ONE TOUCH II METER
K895911 · Lifescan, Inc. · Nov 1989
COBAS READY GLUCOSE REAGENT
K895526 · Roche Diagnostic Systems, Inc. · Oct 1989